Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 297-854-1 | CAS number: 93763-35-0 A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1990-08-05 to 1992-05-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it was carried out according to EPA OTS 798.1175 and equivalent or similar to OECD TG 420.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1175 (Acute Oral Toxicity)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- 68333-23-3
- Cas Number:
- 68333-23-3
- IUPAC Name:
- 68333-23-3
- Reference substance name:
- Thermocracked kerosine
- IUPAC Name:
- Thermocracked kerosine
- Test material form:
- other: low viscosity liquid hydrocarbon
- Details on test material:
- - Name of test material: F-133, thermocracked kerosine, CAS No. 68333-23-3
- Substance type:
- Physical state: transparent, colourless to light yellow coloured liquid; petroleum naphtha odor
- Analytical purity: 100% petroleum hydrocarbons
- Storage condition of test material: test material was stored at temperature below 27 degrees Celsius
- pH: 5
- Density: 0.8965 g/ml
- Specific gravity: approximately 0.74
- Flash point: approximately -43 °C
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bantin & Kingman, Fremont, CA
- Age at study initiation: young adults (eight to twelve weeks old)
- Weight at study initiation: approximately 200 to 350 grams pre-fasting
- Fasting period before study: animals were not fed the night before dosing
- Housing: individually housed in stainless steel, wire mesh bottom cages
- Diet: fresh certified Agway rodent feed provided ad libitum, feed was withheld the night before dosing
- Water: fresh potable water was provided ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 26 degrees Celsius, within protocol limits
- Humidity (%): 40 to 70%, within protocol limits
- Air changes (per hr): no less than ten air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES: From: 1990-08-05 To: 1990-10-01
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- No vehicle, test substance was administered in undiluted form
MAXIMUM DOSE VOLUME APPLIED: 5000 mg/kg bw
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- five males and five females
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: fourteen days
- Frequency of observations and weighing: animals were observed hourly for first four hours after dosing and twice daily for the following fourteen days; animals were weighed when acquired by the testing facility, prior to fasting, prior to test administration, and on days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, external evaluation at necropsy - Statistics:
- The mean and standard deviation for body weight data were calculated
Results and discussion
- Preliminary study:
- The oral limit test resulted in no mortality at a dose level of 5000 mg/kg bw therefore, no further testing was done.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- other: Based on lack of mortality and systemic effects
- Mortality:
- No animals died during the testing period
- Clinical signs:
- other: All of the study animals exhibited one or more of the following clinical signs: nasal discharge, ocular discharge, abnormal stools, lethargy, stained coat, and alopecia.
- Gross pathology:
- At necropsy, one of the ten animals exhibited visual lesions, the remaining nine showed signs of alopecia in the inguinal and/or perineal regions.
Any other information on results incl. tables
No
mortalities in the study.
Clinical signs were:
nasal
discharge in 1/10 animals - cleared by day 2
ocular discharge in 1/10 animals - cleared by day 2
Loose stools in 2/10 animals - cleared by day 2
Lethargy in 1/10 animals - cleared by day 2
Stained coat in 10/10 animals - cleared by day 4
Alopecia in 10/10 animals to 9/10 animals day 14.
All animals gained weight during the study.
There were no abnormalities at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for thermocracked kerosine is greater than 5000 mg/kg bw in Sprague Dawley rats under the conditions of this study.
- Executive summary:
In an acute oral toxicity study, groups of fasted, young adult, Sprague Dawley rats, five male and five female, were given a single oral dose of undiluted thermocracked kerosine at a dose of 5000 mg/kg bw and observed for 14 days.
There were no treatment related mortalities. All of the study animals exhibited one or more of the following clinical signs: nasal discharge, ocular discharge, abnormal stools, lethargy, stained coat, and alopecia. All animals gained weight during study period. At necropsy, one of the ten animals exhibited visual lesions, the remaining nine showed signs of alopecia in the inguinal and/or perineal regions. The oral LD50 was determined to be greater than 5000 mg/kg in males and females.
This study received a Klimisch score of 1 and is classified as reliable without restriction because it was carried out according to EPA OTS 798.1175 and equivalent or similar to OECD TG 420.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.